• banner_04.jpg
  • banner_01.jpg
  • banner_06.jpg
  • banner_05.jpg
  • banner_02.jpg
  • banner_11.jpg
  • banner_03.jpg
  • banner_12.jpg
  • banner_07.jpg
  • banner_10.jpg
  • banner_08.jpg
  • banner_09.jpg
 

Pubblicazioni

  • Chiaretti A, Barone G, Rigante D, Ruggiero A, Pierri F, Barbi E, Barone G, Riccardi R. Intranasal lidocaine and midazolam for procedural sedation in children. Arch Dis Child. 2010 Oct 27. [Epub ahead of print]
  • Geoerger B, Hargrave D, Thomas F, Ndiaye A, Frappaz D, Andreiuolo F, Varlet P, Aerts I, Riccardi R, Jaspan T, Chatelut E, Le Deley MC, Paoletti X, Saint-Rose C, Leblond P, Morland B, Gentet JC, Méresse V, Vassal G; on behalf of the ITCC (Innovative Therapies for Children with Cancer) European Consortium. Innovative Therapies for Children with Cancer pediatric phase I study of erlotinib in brainstem glioma and relapsing/refractory brain tumors. Neuro Oncol. 2010 Oct 25. [Epub ahead of print]
  • Geoerger B, Chisholm J, Le Deley MC, Gentet JC, Zwaan CM, Dias N, Jaspan T, Mc Hugh K, Couanet D, Hain S, Devos A, Riccardi R, Cesare C, Boos J, Frappaz D, Leblond P, Aerts I, Vassal G; on behalf of the European Consortium Innovative Therapies for Children with Cancer (ITCC). Phase II study of gemcitabine combined with oxaliplatin in relapsed or refractory paediatric solid malignancies: An innovative therapy for children with Cancer European Consortium Study. Eur J Cancer. 2010 Oct 11. [Epub ahead of print]
  • Ridola V, Barone G, Lazzareschi I, Ruggiero A, Rizzo D, Riccardi R. Feasibility study of 21-day-on/7-day-off temozolomide in children with brain tumors. J Neurooncol. 2010 Sep 3. [Epub ahead of print]
  • Cefalo MG, Maurizi P, Arlotta A, Scalzone M, Attinà G, Ruggiero A, Riccardi R. Hepatic veno-occlusive disease: a chemotherapy-related toxicity in children with malignancies.
  • Paediatr Drugs. 2010 Oct 1;12(5):277-84.
  • Ruggiero A, Rizzo D, Attinà G, Lazzareschi I, Mastrangelo S, Maurizi P, Migliorati R, Bertolini P, Pastore M, Colosimo C, Riccardi R.Phase I study of temozolomide combined with oral etoposide in children with recurrent or progressive medulloblastoma. Eur J Cancer. 2010 Nov;46(16):2943-9. Epub 2010 Jun 9.
  • Mastrangelo S, Lauriola L, Coccia P, Puma N, Massimi L, Riccardi R. Two cases of pediatric high-grade astroblastoma with different clinical behavior. Tumori. 2010 Jan-Feb;96(1):160-3.
  • Scalzone M, Coccia P, Cerchiara G, Maurizi P, Mastrangelo S, Ruggiero A, Riccardi R. Errors involving patients receiving intrathecal chemotherapy. J Chemother. 2010 Apr;22(2):83-7.
  • Scalzone M, Coccia P, Ruggiero A, Riccardi R. Neurofibromatosis type 1 clinical features and management. Pediatr Med Chir. 2009 Nov-Dec;31(6):246-51.
  • Zwaan CM, Kearns P, Caron H, Verschuur A, Riccardi R, Boos J, Doz F, Geoerger B, Morland B, Vassal G; 'innovative therapies for children with cancer' European consortium. The role of the 'innovative therapies for children with cancer' (ITCC) European consortium.
  • Cancer Treat Rev. 2010 Jun;36(4):328-34. Epub 2010 Mar 15. Review.
  • Lazzareschi I, Furfaro IF, Coccia P, Puma N, Riccardi R. Extragonadal yolk sac tumor outside of the midline of the body: a case report of a child with a yolk sac tumor of the pontocerebellar angle.
  • Tumori. 2009 Nov-Dec;95(6):840-2.
  • Lazzareschi I, Barone G, Mastrangelo S, Furfaro IF, Rando G, Riccardi R. Could APC gene screening be useful in children with hepatoblastoma? Early onset of adenocarcinoma in a child with familial adenomatous polyposis and hepatoblastoma. Tumori. 2009 Nov-Dec;95(6):819-22.
  • Ruggiero A, Barone G, Margani G, Nanni L, Pittiruti M, Riccardi R. Groshong catheter-related complications in children with cancer. Pediatr Blood Cancer. 2010 Jul 1;54(7):947-51.
  • Ruggiero A, Coccia P, Scalzone M, Attinà G, Riccardi R. Treatment of childhood sarcoma with irinotecan: bilirubin level as a predictor of gastrointestinal toxicity. J Chemother. 2009 Dec;21(6):693-7.
  • Cefalo MG, Ruggiero A, Maurizi P, Attinà G, Arlotta A, Riccardi R. Pharmacological management of chemotherapy-induced nausea and vomiting in children with cancer. J Chemother. 2009 Dec;21(6):605-10. Review.
  • Mastrangelo S, Arlotta A, Cefalo MG, Maurizi P, Cianfoni A, Riccardi R. Central pontine and extrapontine myelinolysis in a pediatric patient following rapid correction of hypernatremia. Neuropediatrics. 2009 Jun;40(3):144-7. Epub 2009 Dec 17.
  • Riccardi R, Barone G. [Severe infections in immunodepressed children]
    Minerva Pediatr. 2009 Dec;61(6):854-6.
  • Bisogno G, Riccardi R, Scagnellato A, Arcamone G, Miglionico L, Carli M. No effect of irinotecan in patients with resistant desmoplastic small round cell tumor. Pediatr Blood Cancer. 2010 Jan;54(1):182-3.
  • Ruggiero A, Rizzo D, Mastrangelo S, Battaglia D, Attinà G, Riccardi R. Interactions between antiepileptic and chemotherapeutic drugs in children with brain tumors: is it time to change treatment? Pediatr Blood Cancer. 2010 Feb;54(2):193-8. Review.
  • Chiaretti A, Barone G, Riccardi R, Antonelli A, Pezzotti P, Genovese O, Tortorolo L, Conti G. NGF, DCX, and NSE upregulation correlates with severity and outcome of head trauma in children.
  • Neurology. 2009 Feb 17;72(7):609-16.
  • Buonuomo PS, Maurizi P, Bracaglia C, Margani G, Riccardi R. Primary Sjögren's syndrome mimicking lymphoma in a pediatric patient. A rare and possibly misdiagnosed condition.
    Minerva Pediatr. 2009 Feb;61(1):119-22.
  • Ruggiero A, Rizzo D, Mastrangelo S, Battaglia D, Attinà G, Riccardi R.Interactions between antiepileptic and chemotherapeutic drugs in children with brain tumors: Is it time to change treatment?. Pediatr Blood Cancer. 2009 Sep 3. [Epub ahead of print]
  • Ruggiero A, Attinà G, Piastra M, Maurizi P, Mastrangelo S, Pietrini D, Riccardi R. Severe hyperleukocytosis and multifocal intracranial haemorrhage: not always a fatal outcome. Int J Hematol. 2009 Jul;90(1):87-90.
  • Chiaretti A, Ruggiero A, Barone G, Antonelli A, Lazzareschi I, Genovese O, Paiano S, Sammartino M, Maurizi P, Riccardi R. Propofol/alfentanil and propofol/ketamine procedural sedation in children with acute lymphoblastic leukaemia: safety, efficacy and their correlation with pain neuromediator expression. Eur J Cancer Care (Engl). 2009 May 21. [Epub ahead of print]
  • Ferretti E, De Smaele E, Po A, Di Marcotullio L, Tosi E, Espinola MS, Di Rocco C, Riccardi R, Giangaspero F, Farcomeni A, Nofroni I, Laneve P, Gioia U, Caffarelli E, Bozzoni I, Screpanti I, Gulino A. MicroRNA profiling in human medulloblastoma. Int J Cancer. 2009 Feb 1;124(3):568-77.
  • Attinà G, Ruggiero A, Maurizi P, Arlotta A, Chiaretti A, Riccardi R. Transdermal buprenorphine in children with cancer-related pain. Pediatr Blood Cancer. 2009 Jan;52(1):125-7.
  • Attinà G, Ruggiero A, Maurizi P, Arlotta A, Chiaretti A, Riccardi R. Transdermal buprenorphine in children with cancer-related pain. Pediatr Blood Cancer. 2009 Jan;52(1):125-7.
  • Ruggiero A, Ridola V, Puma N, Molinari F, Coccia P, De Rosa G, Riccardi R. Anthracycline cardiotoxicity in childhood. Pediatr Hematol Oncol. 2008 Jun;25(4):261-81. Review.
  • Falsini B, Ziccardi L, Lazzareschi I, Ruggiero A, Placentino L, Dickmann A, Liotti L, Piccardi M, Balestrazzi E, Colosimo C, Di Rocco C, Riccardi R. Longitudinal assessment of childhood optic gliomas: relationship between flicker visual evoked potentials and magnetic resonance imaging findings. J Neurooncol. 2008 May;88(1):87-96.
  • Ruggiero A, Molinari F, Coccia P, Attinà G, Maurizi P, Riccardi R, Bonomo L. MRI findings in Shwachman diamond syndrome. Pediatr Blood Cancer. 2008 Feb;50 2): 352-4.
  • Ridola V, Buonuomo PS, Maurizi P, Putzulu R, Annunziata ML, Pietrini D, Riccardi R. Severe acute hypertriglyceridemia during acute lymphoblastic leukemia induction successfully treated with plasmapheresis. Pediatr Blood Cancer. 2008 Feb;50(2):378-80.
  • Lazzareschi I, Barone G, Ruggiero A, Liotti L, Maurizi P, Larocca LM, Riccardi R. Paediatric Kikuchi-Fujimoto disease: a benign cause of fever and lymphadenopathy. Pediatr Blood Cancer. 2008 Jan;50(1):119-23.
  • Ruggiero A, Buonuomo PS, Maurizi P, Cefalo MP, Corsello M, Riccardi R. Stevens-Johnson syndrome in children receiving phenobarbital therapy and cranial radiotherapy. J Neuro-Oncol. 2007 Nov;85(2):213-5. Epub 2007 Jun 23.
  • Ruggiero A, Barone G, Liotti L, Chiaretti A, Lazzareschi I, Riccardi R. Safety and efficacy of fentanyl administered by patient controlled analgesia in children with cancer pain. Support Care Cancer. 2007 May;15(5):569-73. Epub 2006 Dec 5.
  • Petraroli M, D’Alessioo E, Ausili E, Barini A, Caradonna P, Riccardi R, Caldarelli M, Rossodivita A. Bone mineral density in survivors of childhood brain tumors. Child Nervous System. 2007 Jan; 23(1):59-65.
  • Modena P, Lualdi E, Facchinetti F, Veltman J, Reid JF, Minardi S, Janssen I, Giangaspero F, Forni M, Finocchiaro G, Genitori L, Giordano F, Riccardi R, et al. Identification of tumor-specific molecular signatures in intracranial ependymoma and association with clinical characteristics. J Clin Oncol 2006 Nov 20;24(33):5223-33.
  • Ferretti E, Di Marcotullio L, Gessi M, Mattei T, Greco A, Po A, De Smaele E, Giangaspero F, Riccardi R, et al. Alternative splicing of the ErbB-4 cytoplasmic domain 24and its regulation by hedgehog signaling identify distinct medulloblastoma subsets. O25ncogene. 2006 25(55):7267-73. Epub 2006 Jul 31.
  • Ruggiero A., Annunziata M.L., Lazzareschi I., Ridola V., Attinà G., Riccardi R.“Chr27onic idiopathic thrombocytopenia purpura in children: case reports of spontane28ous recovery without splenectomy”.Pediatr Hematol Oncol 2006; 23: 471-475.
  • Ruggiero A, Cefalo G, Garrè ML, Massimino M, Colosimo C, Attinà G, Lazzareschi I, Maurizi P, Ridola V, Mazzarella G, Caldarelli M, Di Rocco C, Madon E, Abate ME, Clerico A, Sandri A, Riccardi R. Phase II trial of temozolomide in children with recurrent high-grade glioma. J Neuro-Oncol 2006; 77(1):89-94.
  • Barone G, Maurizi P, Tamburrini G, Riccardi R. Role of Temozolomide in pediatric brain tumors. Child Nervous System. 2006 Jul; 22(7):652-661.
  • Martinelli S, Carta C, Flex E, Binni F, Luci Cordisco E, Moretti S, Puxeddu E, Tonacchera M, Pinchera A, McDowell HP, Dominici C, Rosolen A, Di Rocco C, Riccardi R, et al.. Activating PTPN11 mutations play a minor role in pediatric and adult solid tumors. Cancer Genetics and Cytogenetics, 2006; 166(2):124-9.
  • Ruggiero A, Attinà G, Maurizi P, Mulè A, Tarquini E, Barone G, Lazzareschi I, Riccardi R. Rosai-Dorfman disease: two case reports and diagnostic role of fine-needle aspiration cytology. J Pediatr Hematol Oncol. 2006 Feb;28(2):103-6.
  • Bisogno G, Riccardi R, et al. Phase II study of a protracted Irinotecan schedule in children with refractory or recurrent sarcomas. Cancer , 2006; 106(3):703-7.
  • Meco D, Servidei T, Zannoni GF, Martinelli E, Prisco MG, de Waure C, Riccardi R. Dual Inhibitor AEE788 Reduces Tumor Growth in Preclinical Models of Medulloblastoma. Transl Oncol. 2010 Oct 1;3(5):326-35.
  • Zucchetti M, Meco D, Di Francesco AM, Servidei T, Patriarca V, Cusano G, D'Incalci M, Forestieri D, Pisano C, Riccardi R. Antitumor activity and pharmacokinetics of oral gimatecan on pediatric cancer xenografts. Cancer Chemother Pharmacol. 2010 Sep;66(4):635-41. Epub 2009 Dec 20.
  • Meco D, Servidei T, Riccardi A, Ferlini C, Cusano G, Zannoni GF, Giangaspero F, Riccardi R. Antitumor effect in medulloblastoma cells by gefitinib: Ectopic HER2 overexpression enhances gefitinib effects in vivo. Neuro Oncol. 2009 Jun;11(3):250-9. Epub 2008 Nov 25.
  • Ferretti E, De Smaele E, Po A, Di Marcotullio L, Tosi E, Espinola MS, Di Rocco C, Riccardi R, Giangaspero F, Farcomeni A, Nofroni I, Laneve P, Gioia U, Caffarelli E, Bozzoni I, Screpanti I, Gulino MicroRNA profiling in human medulloblastoma. A. Int J Cancer. 2009 Feb 1;124(3):568-77.
  • Servidei T, Riccardi A, Mozzetti S, Ferlini C, Riccardi R. Chemoresistant tumor cell lines display altered epidermal growth factor receptor and HER3 signaling and enhanced sensitivity to gefitinib. Int J Cancer. 2008 Dec 15;123(12):2939-49.
  • Meco D, Servidei T, Riccardi A, Ferlini C, Cusano G, Zannoni GF, Giangaspero F, Riccardi R. Antitumor effect in medulloblastoma cells by gefitinib: Ectopic HER2 overexpression enhances gefitinib effects in vivo. Neuro Oncol. 2009 Jun;11(3):250-9. Epub 2008 Nov 25.
  • Valli C, Paroni G, Di Francesco AM, Riccardi R, Tavecchio M, Erba E, Boldetti A, Gianni' M, Fratelli M, Pisano C, Merlini L, Antoccia A, Cenciarelli C, Terao M, Garattini E. Atypical retinoids ST1926 and CD437 are S-phase-specific agents causing DNA double-strand breaks: significance for the cytotoxic and antiproliferative activity. Mol Cancer Ther. 2008 Sep;7(9):2941-54.
  • McDowell HP, Meco D, Riccardi A, Tanno B, Berardi AC, Raschellà G, Riccardi R, Dominici C. Imatinib mesylate potentiates topotecan antitumor activity in rhabdomyosarcoma preclinical models. Int J Cancer. 2007 Mar 1;120(5):1141-9.
  • Di Francesco AM, Meco D, Torella AR, Barone G, D'Incalci M, Pisano C, Carminati P, Riccardi R. The novel atypical retinoid ST1926 is active in ATRA resistant neuroblastoma cells acting by a different mechanism. Biochem Pharmacol. 2007 Mar 1;73(5):643-55. Epub 2006 Nov 7.
  • Wong KK, Tsang YT, Chang YM, Su J, Di Francesco AM, Meco D, Riccardi R, Perlaky L, Dauser RC, Adesina A, Bhattacharjee M, Chintagumpala M, Lau CC. Genome-wide allelic imbalance analysis of pediatric gliomas by single nucleotide polymorphic allele array. Cancer Res. 2006 Dec 1;66(23):11172-8.
  • Servidei T, Riccardi A, Sanguinetti M, Dominici C, Riccardi R. Increased sensitivity to the platelet-derived growth factor (PDGF) receptor inhibitor STI571 in chemoresistant glioma cells is associated with enhanced PDGF-BB-mediated signaling and STI571-induced Akt inactivation. J Cell Physiol. 2006 Jul;208(1):220-8.